TI
RLAY icon

TrueMark Investments’s Relay Therapeutics RLAY Stock Holding History

TrueMark Investments’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-49,628
Closed -$172K – 224
2025
Q2 		$172K Sell
49,628
-1,908
-4% -$5.67K 0.04% 139
2025
Q1 		$135K Sell
51,536
-3,864
-7% -$15.1K 0.04% 174
2024
Q4 		$228K Sell
55,400
-4,604
-8% -$25.1K 0.07% 129
2024
Q3 		$425K Buy
60,004
+5,559
+10% +$41.5K 0.14% 137
2024
Q2 		$355K Hold
54,445
– – 0.12% 156
2024
Q1 		$452K Buy
54,445
+6,487
+14% +$63.3K 0.41% 51
2023
Q4 		$528K Buy
+47,958
New +$405K 0.53% 51

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TrueMark Investments's RLAY Position: Q3 2025 in Review

TrueMark Investments sold out of Relay Therapeutics (RLAY) in Q3 2025, closing a stake of 49,628 shares — an estimated $172K sold.

TrueMark Investments first reported a position in RLAY in Q4 2023 and held it in 7 quarters. The position peaked at $528K in Q4 2023. 199 funds tracked by Wall St. Rank hold RLAY as of Q3 2025.

  • TrueMark Investments reported no remaining Relay Therapeutics position as of Q3 2025 after selling out during the quarter.
  • TrueMark Investments sold 49,628 Relay Therapeutics shares in Q3 2025, an estimated $172K.
  • TrueMark Investments first reported a position in Relay Therapeutics in Q4 2023 and held it in 7 quarters.
  • TrueMark Investments's Relay Therapeutics position peaked at $528K in Q4 2023.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2025.

Based on TrueMark Investments's 13F filing for Q3 2025, filed 30 Oct 2025.